Join
Live feed
·
INSIDERFilingvia Quantisnow
Pressure BioSciences, Inc. logo

SEC Form 4: Pollack Kevin acquired $956 worth of shares (771 units at $1.24), increasing direct ownership by 3% to 25,172 units

ByQuantisnow·Wall Street's wire, on your screen.
PBIO· Pressure BioSciences, Inc.
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PBIO (Pressure BioSciences, Inc.) and more on Quantisnow.